Therefore, we could hypothesize that deregulated TLR6 may not only contribute to the chronic and systemic pro-inflammatory state related to obesity, mirroring the inflammation that is taking place within the liver, but also actively participate in the disease development and progression of obese NAFLD. The gene discussed is TLR6; the disease is obesity disorder.